Nkarta (NKTX) Receivables - Accured (2019 - 2026)
Nkarta (NKTX) posted Receivables - Accured of $2.1 million for Q2 2026, down 4.5% from $2.2 million a year earlier but up 23.5% from the prior quarter.
Powered by 
Analysis
Nkarta (NKTX) Receivables - Accured (2019 - 2026) Analysis & Trends
At the end of FY2025, Nkarta's Receivables - Accured came in at $2 million, down 20.0% from FY2024.
- Annual Receivables - Accured shows a five-year compound annual growth rate of 12.7% (FY2020 to FY2025).
- In prior years, Nkarta's Receivables - Accured was $2.5 million in FY2024 (+108.3%), $1.2 million in FY2023 (+50.0%), $800,000 in FY2022 (-20.0%) and $1 million in FY2021 (-9.1%).
- Quarterly Receivables - Accured has run from a low of $600,000 in Q1 2023 to a high of $2.5 million in Q4 2024 over five years.
- On a year-over-year basis, Receivables - Accured has declined in each of the last four quarters, with growth averaging 40.1% over the last eight quarters.
- The strongest year-over-year quarter for Receivables - Accured in the past five years was Q3 2021, with growth of 200.0%; the weakest was Q1 2023, with a decline of 40.0%.
- According to Business Quant data, Receivables - Accured for the three prior quarters was $1.7 million (Q1 2026), $2 million (Q4 2025) and $2.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Accured (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | - |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | - |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | - |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | - |
| 10 | Nkarta | 187.66 Mn | 187.66 Mn | - | 2.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.10 Mn |
| Mar 31, 2026 | 1.70 Mn |
| Dec 31, 2025 | 2.00 Mn |
| Sep 30, 2025 | 2.10 Mn |
| Jun 30, 2025 | 2.20 Mn |
| Mar 31, 2025 | 2.40 Mn |
| Dec 31, 2024 | 2.50 Mn |
| Sep 30, 2024 | 2.50 Mn |
| Jun 30, 2024 | 2.10 Mn |
| Mar 31, 2024 | 1.20 Mn |
| Dec 31, 2023 | 1.20 Mn |
| Sep 30, 2023 | 900,000.00 |
| Jun 30, 2023 | 900,000.00 |
| Mar 31, 2023 | 600,000.00 |
| Dec 31, 2022 | 800,000.00 |
| Sep 30, 2022 | 1.30 Mn |
| Jun 30, 2022 | 1.00 Mn |
| Mar 31, 2022 | 1.00 Mn |
| Dec 31, 2021 | 1.00 Mn |
| Sep 30, 2021 | 900,000.00 |
API Access
Nkarta Receivables - Accured API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-accured&ticker=NKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-accured", "ticker": "NKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-accured&ticker=NKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();